These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 19729658)
1. Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a. Fine B; Hodakoski C; Koujak S; Su T; Saal LH; Maurer M; Hopkins B; Keniry M; Sulis ML; Mense S; Hibshoosh H; Parsons R Science; 2009 Sep; 325(5945):1261-5. PubMed ID: 19729658 [TBL] [Abstract][Full Text] [Related]
3. MiR-637 suppresses melanoma progression through directly targeting P-REX2a and inhibiting PTEN/AKT signaling pathway. Zhang J; Liu WL; Zhang L; Ge R; He F; Gao TY; Tian Q; Mu X; Chen LH; Chen W; Li X Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):50-57. PubMed ID: 30213289 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-561 Affects Proliferation and Cell Cycle Transition Through PTEN/AKT Signaling Pathway by Targeting P-REX2a in NSCLC. Liao Z; Zheng Q; Wei T; Zhang Y; Ma J; Zhao Z; Sun H; Nan K Oncol Res; 2020 Mar; 28(2):147-159. PubMed ID: 31711559 [TBL] [Abstract][Full Text] [Related]
5. PTEN-deficient cancers depend on PIK3CB. Wee S; Wiederschain D; Maira SM; Loo A; Miller C; deBeaumont R; Stegmeier F; Yao YM; Lengauer C Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13057-62. PubMed ID: 18755892 [TBL] [Abstract][Full Text] [Related]
6. miR-338-3p suppresses gastric cancer progression through a PTEN-AKT axis by targeting P-REX2a. Guo B; Liu L; Yao J; Ma R; Chang D; Li Z; Song T; Huang C Mol Cancer Res; 2014 Mar; 12(3):313-21. PubMed ID: 24375644 [TBL] [Abstract][Full Text] [Related]
7. Interference of P-REX2a may inhibit proliferation and reverse the resistance of SGC7901 cells to doxorubicin. Ai Y; Zhou Q; Li L; Pan Z; Guo M; Han J Oncol Lett; 2018 Mar; 15(3):3185-3191. PubMed ID: 29435055 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K/Akt signaling pathway. Wang F; Li L; Chen Z; Zhu M; Gu Y Int J Mol Med; 2016 May; 37(5):1421-8. PubMed ID: 26951965 [TBL] [Abstract][Full Text] [Related]
9. PTEN sensitizes MDA-MB-468 cells to inhibition of MEK/Erk signaling for the blockade of cell proliferation. Jang K; Kim M; Seo HS; Shin I Oncol Rep; 2010 Sep; 24(3):787-93. PubMed ID: 20664988 [TBL] [Abstract][Full Text] [Related]
10. Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer. De Marco C; Laudanna C; Rinaldo N; Oliveira DM; Ravo M; Weisz A; Ceccarelli M; Caira E; Rizzuto A; Zoppoli P; Malanga D; Viglietto G PLoS One; 2017; 12(6):e0178865. PubMed ID: 28662101 [TBL] [Abstract][Full Text] [Related]
11. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast. Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452 [TBL] [Abstract][Full Text] [Related]
12. Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migration of human melanoma cells and elicits PTEN elevation and inactivation of PI3K/AKT signaling. Foster JS; Fish LM; Phipps JE; Bruker CT; Lewis JM; Bell JL; Solomon A; Kestler DP BMC Cancer; 2013 May; 13():227. PubMed ID: 23648148 [TBL] [Abstract][Full Text] [Related]
13. Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CA. Kim JS; Lee C; Bonifant CL; Ressom H; Waldman T Mol Cell Biol; 2007 Jan; 27(2):662-77. PubMed ID: 17060456 [TBL] [Abstract][Full Text] [Related]
14. PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells. Ma J; Sawai H; Ochi N; Matsuo Y; Xu D; Yasuda A; Takahashi H; Wakasugi T; Takeyama H Mol Cell Biochem; 2009 Nov; 331(1-2):161-71. PubMed ID: 19437103 [TBL] [Abstract][Full Text] [Related]
15. PTEN, more than the AKT pathway. Blanco-Aparicio C; Renner O; Leal JF; Carnero A Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655 [TBL] [Abstract][Full Text] [Related]
16. MADD is a downstream target of PTEN in triggering apoptosis. Jayarama S; Li LC; Ganesh L; Mardi D; Kanteti P; Hay N; Li P; Prabhakar BS J Cell Biochem; 2014 Feb; 115(2):261-70. PubMed ID: 24038283 [TBL] [Abstract][Full Text] [Related]
17. Methylation and mutation of the inhibin‑α gene in human melanoma cells and regulation of PTEN expression and AKT/PI3K signaling by a demethylating agent. Ko H; Ahn HJ; Kim YI Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34958114 [TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor α induces down-regulation of PTEN through PI3-kinase activation in breast cancer cells. Noh EM; Lee YR; Chay KO; Chung EY; Jung SH; Kim JS; Youn HJ Mol Med Rep; 2011; 4(2):215-9. PubMed ID: 21468554 [TBL] [Abstract][Full Text] [Related]
19. Regulation of PTEN inhibition by the pleckstrin homology domain of P-REX2 during insulin signaling and glucose homeostasis. Hodakoski C; Hopkins BD; Barrows D; Mense SM; Keniry M; Anderson KE; Kern PA; Hawkins PT; Stephens LR; Parsons R Proc Natl Acad Sci U S A; 2014 Jan; 111(1):155-60. PubMed ID: 24367090 [TBL] [Abstract][Full Text] [Related]
20. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells. Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]